Pharmacogenomics Technology Market Size, Share & Trends Report

Pharmacogenomics Technology Market (2025 - 2030) Size, Share & Trends Analysis Report By Therapeutic Area (Neurological Disorders, Cardiovascular Disease), By Technology (PCR, In-situ Hybridization), By Region, And Segment Forecasts

Market Segmentation

Pharmacogenomics Technology Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
  - Lung Cancer
  - Breast Cancer
  - Colorectal Cancer
  - Cervical Cancer
  - Others
- Neurological Disorders
- Cardiovascular Disease
- Immunological Disorders
- Infectious Diseases
- Others
Pharmacogenomics Technology Outlook (Revenue, USD Million, 2018 - 2030)
- PCR
- In-situ Hybridization
- Immunohistochemistry
- Sequencing
- Others
Pharmacogenomics Technology Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Neurological Disorders
    - Cardiovascular Disease
    - Immunological Disorders
    - Infectious Diseases
    - Others
  - North America Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - PCR
    - In-situ Hybridization
    - Immunohistochemistry
    - Sequencing
    - Others
  - U.S.
    - U.S. Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - U.S. Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Canada
    - Canada Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Canada Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Mexico
    - Mexico Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Mexico Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
- Europe
  - Europe Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Neurological Disorders
    - Cardiovascular Disease
    - Immunological Disorders
    - Infectious Diseases
    - Others
  - Europe Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - PCR
    - In-situ Hybridization
    - Immunohistochemistry
    - Sequencing
    - Others
  - U.K.
    - U.K. Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - U.K. Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Germany
    - Germany Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Germany Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - France
    - France Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - France Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Italy
    - Italy Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Italy Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Spain
    - Spain Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Spain Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Sweden
    - Sweden Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Sweden Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Norway
    - Norway Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Norway Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Denmark
    - Denmark Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Denmark Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
- Asia Pacific
  - Asia Pacific Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Neurological Disorders
    - Cardiovascular Disease
    - Immunological Disorders
    - Infectious Diseases
    - Others
  - Asia Pacific Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - PCR
    - In-situ Hybridization
    - Immunohistochemistry
    - Sequencing
    - Others
  - Japan
    - Japan Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Japan Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - China
    - China Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - China Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - India
    - India Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - India Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Australia
    - Australia Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Australia Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Thailand
    - Thailand Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Thailand Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - South Korea
    - South Korea Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - South Korea Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
- Latin America
  - Latin America Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Neurological Disorders
    - Cardiovascular Disease
    - Immunological Disorders
    - Infectious Diseases
    - Others
  - Latin America Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - PCR
    - In-situ Hybridization
    - Immunohistochemistry
    - Sequencing
    - Others
  - Brazil
    - Brazil Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Brazil Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Argentina
    - Argentina Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Argentina Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
- Middle East and Africa
  - Middle East and Africa Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
      - Lung Cancer
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Others
    - Neurological Disorders
    - Cardiovascular Disease
    - Immunological Disorders
    - Infectious Diseases
    - Others
  - Middle East and Africa Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - PCR
    - In-situ Hybridization
    - Immunohistochemistry
    - Sequencing
    - Others
  - Saudi Arabia
    - Saudi Arabia Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Saudi Arabia Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - South Africa
    - South Africa Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - South Africa Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - UAE
    - UAE Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - UAE Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others
  - Kuwait
    - Kuwait Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
        
        Lung Cancer
        
        Breast Cancer
        
        Colorectal Cancer
        
        Cervical Cancer
        
        Others
      - Neurological Disorders
      - Cardiovascular Disease
      - Immunological Disorders
      - Infectious Diseases
      - Others
    - Kuwait Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - PCR
      - In-situ Hybridization
      - Immunohistochemistry
      - Sequencing
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments